...
首页> 外文期刊>Obstetrics, gynaecology and reproductive medicine >Surgical management of tubal disease and infertility
【24h】

Surgical management of tubal disease and infertility

机译:输卵管疾病和不孕症的外科治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

With the advance in assisted reproductive technology (ART), the role of reproductive surgery as the primary treatment of infertility has been questioned. Tubo-peritoneal factor is common, and accounts for 30-40% of female infertility. The pathology of tubal disease ranges from peritubal adhesion, proximal and/or distal tubal blockage, hydrosalpinx to previous sterilization. In tubo-peritoneal infertility, reproductive surgery remains an important option and is complementary to ART. It should be considered as the first-line treatment if a good result is expected when the pathology is amendable or if untreated will adversely affect the results or increase the risks of ART. The success of reproductive surgery depends on careful patient selection using proper investigative tools, performed in units with expertise following microsurgical principles.
机译:随着辅助生殖技术(ART)的发展,生殖外科作为不孕症的主要治疗方法的作用受到质疑。腹膜腹膜因子是常见的,占女性不育症的30-40%。输卵管疾病的病理学范围从周围粘连,近端和/或远端输卵管阻塞,输卵管积水到先前的绝育。在肾小管-腹膜不育症中,生殖手术仍然是重要的选择,并且是ART的补充。如果在可改变的病理状态下预期获得良好的结果,或者如果不进行治疗会对结果产生不利影响或增加ART的风险,则应视为一线治疗。生殖手术的成功取决于使用适当的研究工具对患者进行仔细选择,这些研究工具应按照显微手术原则在具有专业知识的单位中进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号